Development and Validation of the Amphetamine-Type Stimulants Motive Questionnaire in a Clinical Population





Faculty/Professorship: Pathopsychology  
Author(s): Thurn, Daniela ; Kuntsche, Emmanuel; Weber, Jennifer Anna; Wolstein, Jörg  
Title of the Journal: Frontiers in psychiatry
ISSN: 1664-0640
Publisher Information: Lausanne : Frontiers Research Foundation
Year of publication: 2017
Volume: 8
Issue: 183
Pages: 1-8
Language(s): English
Remark: 
Zweitveröffentlichung der Verlagsversion am 08.03.2021
Licence: Creative Commons - CC BY - Attribution 4.0 International 
DOI: 10.3389/fpsyt.2017.00183
Abstract: 
Approximately 35.7 million people world-wide use amphetamine-type stimulants (ATS) leading to a high demand for effective treatment. Understanding the motives behind ATS use is a necessary basis for preventive and therapeutic treatment. The objective of this study is to develop the Amphetamine-Type stimulants Motive Questionnaire (AMQ) and to confirm its construct and concurrent validity in respect to the first and the latest month of ATS use based on answers of 233 patients with ATS disorders (74.2% male; mean age: 31.1 years). Confirmatory factor analyses were employed to test for the construct validity of the AMQ. Nested models of confirmatory factor analyses with increasing constraints for gender and age were estimated to test the equivalence of the factor structure in different subgroups. Independent sample t-tests were conducted to test for mean differences in the motive dimensions. A structural equation model was estimated to confirm the concurrent validity using the latent four motive factors (i.e., enhancement, coping, social, and conformity motives) as independent variables and frequency of ATS use in the first and the latest month of use as a dependent variable. The results confirmed the AMQ’s four-dimensional factor structure in general, and across gender and age groups for both periods of time. Men (first month: M = 4.21, SD = 0.75; latest month: M = 3.86, SD = 0.93) use ATS more frequently due to enhancement motives than women (first month: M = 3.85, SD = 1.12; latest month: M = 3.46, SD = 1.29) at both periods of time [first month: t(77) = −2.33, p = 0.022; latest month: t(80) = −2.19, p = 0.031]. Structural equation modeling confirmed an association between coping motives and use frequency, for both periods of time (first and latest month: β = 0.32, p < 0.001), as well as between social motives and frequency of use for the latest month of use (β = 0.30, p < 0.01). To conclude, the AMQ is a valid and reliable instrument for assessing motives of ATS use in a clinical population. It can provide important insights into the motivational structure of the first and latest months of ATS use which are useful for preventive and therapeutic treatments as well as the development of abstinence skills.
Keywords: amphetamine-type stimulants, confirmatory factor analysis, motives for ATS use, scale development, clinical population
International Distribution: Ja
Open Access Journal: Ja
Type: Article
URI: https://fis.uni-bamberg.de/handle/uniba/42947
Year of publication: 8. December 2017
Project: Open Access Publizieren
Konsummotive bei Konsumenten von amphetaminartigen Substanzen

File SizeFormat  
fisba42947.pdf259.16 kBPDFView/Open